Orthofix Medical (OFIX) Restructuring Costs (2023 - 2024)
Orthofix Medical (OFIX) reported Restructuring Costs of $1.3 million for Q4 2024, up 30.72% year-on-year from $1.0 million in Q1 2024, and up 160.4% quarter-over-quarter from $505000.0 in Q3 2024.
Orthofix Medical (OFIX) has 2 years of Restructuring Costs data on file, last reported at $1.3 million in Q4 2024.
- For the quarter ending Q4 2024, Restructuring Costs rose 30.72% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2024 stood at $9.4 million (down 51.61% YoY), and the FY2024 full-year result was $9.4 million, up 697.28% from the prior year.
- Restructuring Costs for Q4 2024 stood at $1.3 million, up from $505000.0 in the prior quarter.
- Across five years, Restructuring Costs topped out at $18.2 million in Q1 2023 and bottomed at -$92000.0 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Orthofix Medical | 375.38 Mn | 254.51 Mn | 139.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 505,000.00 |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 2.21 Mn |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | -92,000.00 |
| Jun 30, 2023 | 262,000.00 |
| Mar 31, 2023 | 18.20 Mn |